PROCEPT BioRobotics Corporation (NASDAQ: PRCT) reported Q4 EPS of ($0.63), $0.09 worse than the analyst estimate of ($0.54). Revenue for the quarter came in at $23.78 million versus the consensus estimate of $22.91 million.

For earnings history and earnings-related data on PROCEPT BioRobotics Corporation (PRCT) click here.